The Beauty Health Company (NASDAQ:SKIN) Receives Average Recommendation of “Hold” from Brokerages

Shares of The Beauty Health Company (NASDAQ:SKIN) have been given an average rating of “Hold” by the eight brokerages that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company. The average 12-month price target among brokers that have covered the stock in the last year is $2.02.

SKIN has been the topic of a number of recent research reports. Canaccord Genuity Group cut their target price on Beauty Health from $1.50 to $1.00 and set a “hold” rating on the stock in a report on Friday, May 1st. TD Cowen dropped their price objective on shares of Beauty Health from $1.65 to $1.50 and set a “hold” rating on the stock in a research note on Monday, March 16th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Beauty Health in a report on Wednesday, June 24th. Roth Mkm reissued a “buy” rating and set a $2.00 target price (down from $2.50) on shares of Beauty Health in a research report on Wednesday, May 20th. Finally, Benchmark reissued a “hold” rating on shares of Beauty Health in a research report on Friday, March 13th.

Beauty Health Stock Performance

NASDAQ:SKIN opened at $0.72 on Thursday. The company has a quick ratio of 1.48, a current ratio of 1.79 and a debt-to-equity ratio of 4.37. Beauty Health has a twelve month low of $0.55 and a twelve month high of $2.69. The company has a fifty day moving average of $0.72 and a 200-day moving average of $1.04. The firm has a market capitalization of $93.03 million, a P/E ratio of -4.22 and a beta of 1.08.

Beauty Health (NASDAQ:SKIN) last issued its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.04. The business had revenue of $64.91 million for the quarter, compared to analyst estimates of $66.28 million. Beauty Health had a negative net margin of 2.03% and a negative return on equity of 9.38%. As a group, sell-side analysts anticipate that Beauty Health will post -0.14 EPS for the current year.

Institutional Investors Weigh In On Beauty Health

A number of hedge funds and other institutional investors have recently bought and sold shares of SKIN. Capricorn Fund Managers Ltd bought a new stake in Beauty Health during the first quarter valued at $17,270,000. Mirabella Financial Services LLP boosted its stake in shares of Beauty Health by 21.3% in the 3rd quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company’s stock valued at $31,037,000 after purchasing an additional 2,734,728 shares in the last quarter. Woodline Partners LP grew its holdings in shares of Beauty Health by 255.9% during the 3rd quarter. Woodline Partners LP now owns 5,930,027 shares of the company’s stock valued at $11,801,000 after purchasing an additional 4,263,997 shares during the last quarter. Millennium Management LLC grew its holdings in shares of Beauty Health by 127.0% during the 4th quarter. Millennium Management LLC now owns 5,764,802 shares of the company’s stock valued at $8,013,000 after purchasing an additional 3,225,668 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in Beauty Health by 27.5% in the 2nd quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock worth $4,399,000 after purchasing an additional 496,963 shares during the period. Institutional investors own 93.26% of the company’s stock.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.